Immunotech Laboratories Valuation
| IMMB Stock | USD 0.0001 0.00 0.00% |
Immunotech Laboratories seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Immunotech Laboratories from evaluating the firm fundamentals such as Current Valuation of 1.25 M, net income of (977.57 K), and Shares Outstanding of 550.66 K as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Immunotech Laboratories' valuation include:
Overvalued
Today
Please note that Immunotech Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Immunotech Laboratories is based on 3 months time horizon. Increasing Immunotech Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Immunotech Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immunotech Stock. However, Immunotech Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The real value of Immunotech Stock, also known as its intrinsic value, is the underlying worth of Immunotech Laboratories Company, which is reflected in its stock price. It is based on Immunotech Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Immunotech Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Immunotech Laboratories helps investors to forecast how Immunotech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immunotech Laboratories more accurately as focusing exclusively on Immunotech Laboratories' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Immunotech Laboratories' intrinsic value based on its ongoing forecasts of Immunotech Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Immunotech Laboratories' closest peers. If more than one evaluation category is relevant for Immunotech Laboratories we suggest using both methods to arrive at a better estimate.
Immunotech Laboratories Total Value Analysis
Immunotech Laboratories is currently expected to have valuation of 1.25 M with market capitalization of 55, debt of 3.04 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Immunotech Laboratories fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.25 M | 55 | 3.04 M |
Immunotech Laboratories Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Immunotech suggests not a very effective usage of assets in December.Immunotech Laboratories Profitability Analysis
Net Loss for the year was (977.57 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Immunotech Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Immunotech Laboratories and how it compares across the competition.
About Immunotech Laboratories Valuation
The stock valuation mechanism determines Immunotech Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Immunotech Laboratories. We calculate exposure to Immunotech Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Immunotech Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (12.56) | (13.19) | |
| Operating Profit Margin | (24.94) | (26.18) | |
| Net Loss | (12.67) | (13.30) |
Immunotech Laboratories Current Valuation Indicators
Valuation refers to the process of determining the present value of Immunotech Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Immunotech we look at many different elements of the entity such as Immunotech's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Immunotech Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Immunotech Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Immunotech Laboratories' worth.Complementary Tools for Immunotech Stock analysis
When running Immunotech Laboratories' price analysis, check to measure Immunotech Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunotech Laboratories is operating at the current time. Most of Immunotech Laboratories' value examination focuses on studying past and present price action to predict the probability of Immunotech Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunotech Laboratories' price. Additionally, you may evaluate how the addition of Immunotech Laboratories to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |